Microbiology

Search results

• Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant

  Kris White,

  18/01/22 → 20/01/22

  5 items of Media coverage

  Press/Media

• Pfizer says it has successfully tested oral treatment against Omicron variant

  Kris White,

  19/01/22

  1 item of Media coverage

  Press/Media

• Pfizer shares in-vitro efficacy of novel COVID-19 oral treatment against Omicron

  Kris White,

  19/01/22

  1 item of Media coverage

  Press/Media

• Pfizer's antiviral Covid pill shows effectiveness against the Omicron variant in three separate lab tests

  Kris White,

  18/01/22 → 19/01/22

  7 items of Media coverage

  Press/Media

• Pfizer assures that anti-COVID pills are also effective against omicron

  Kris White,

  19/01/22

  2 items of Media coverage

  Press/Media

• COVID-19: Pfizer claims its antiviral pill shows efficacy against Omicron variant

  Kris White,

  19/01/22

  1 item of Media coverage

  Press/Media

• Pfizer shares results from in vitro efficacy of novel Covid-19 oral treatment against Omicron variant

  Kris White,

  19/01/22

  3 items of Media coverage

  Press/Media

• Pfizer’s new pill ‘effective against Omicron’

  Kris White,

  18/01/22

  1 item of Media coverage

  Press/Media

• Pfizer says anticovid pills also effective against omicron

  Kris White,

  18/01/22

  1 item of Media coverage

  Press/Media

• Pfizer Shares In Vitro Efficacy of Paxlovid Novel COVID-19 Oral Treatment Against Omicron Variant

  Kris White,

  18/01/22

  1 item of Media coverage

  Press/Media

• Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants'

  Adolfo Garcia-Sastre,

  11/01/22

  36 items of Media coverage

  Press/Media

• PharmaMar's stock market rises on the efficacy of a covid drug

  Adolfo Garcia-Sastre,

  11/01/22

  1 item of Media coverage

  Press/Media

• PharmaMar's stock market soars after success of its anticovid against Omicron

  Adolfo Garcia-Sastre,

  11/01/22

  1 item of Media coverage

  Press/Media

• COVID-19: Three key facts we still don't know two years into the pandemic

  Florian Krammer,

  9/01/22 → 10/01/22

  3 items of Media coverage

  Press/Media

• Is the omicron variant the beginning of the end of the coronavirus?

  Adolfo Garcia-Sastre,

  23/12/21

  1 item of Media coverage

  Press/Media

• AstraZeneca Vaccine Thrombus Cases Linked to Erroneous Autoimmune Response | Science

  Adolfo Garcia-Sastre,

  13/12/21

  1 item of Media coverage

  Press/Media

• Vaccine protection drops against Omicron, making boosters crucial

  Peter Palese

  9/12/21

  2 items of Media coverage

  Press/Media

• Experts call for booster shots to fight omicron

  Florian Krammer,

  9/12/21

  1 item of Media coverage

  Press/Media

• Vaccine Protection Drops Against Omicron, Making Boosters Crucial

  Peter Palese

  8/12/21 → 9/12/21

  3 items of Media coverage

  Press/Media

• Omicron Not Wholly Evading Pfizer COVID Vaccine in Study Gives Scientists Cause for Hope

  Florian Krammer,

  8/12/21

  1 item of Media coverage

  Press/Media

• Omicron Variant: do we have enough information to make decisions?

  Florian Krammer,

  30/11/21

  1 item of Media coverage

  Press/Media

• "There is no evidence that the delta plus variant reduces the efficacy of vaccines."

  Adolfo Garcia-Sastre,

  11/11/21

  1 item of Media coverage

  Press/Media

• ‘We just have to keep pushing’: Universal flu vaccine remains out of reach, for now

  Adolfo Garcia-Sastre,, Florian Krammer, & Peter Palese

  3/11/21

  1 item of Media coverage

  Press/Media

• What We Know So Far About the Coronavirus Variants

  Viviana Simon

  28/10/21

  2 items of Media coverage

  Press/Media

• A Twindemic? - Will There Be One

  Peter Palese

  18/10/21

  2 items of Media coverage

  Press/Media